Gastric Cancer Guidelines Expert Panel

[1]  F.–C. Zhang,et al.  Capecitabine for the treatment for advanced gastric cancer: efficacy, safety and ethnicity , 2012, Journal of clinical pharmacy and therapeutics.

[2]  Kehu Yang,et al.  ENDOSCOPIC STENTING VERSUS GASTROJEJUNOSTOMY FOR PALLIATION OF MALIGNANT GASTRIC OUTLET OBSTRUCTION , 2012, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[3]  E. Chiorean.  Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study , 2012 .

[4]  L. Helyer,et al.  Effective palliation and quality of life outcomes in studies of surgery for advanced, non-curative gastric cancer: a systematic review , 2012, Gastric Cancer.

[5]  Rinku Sutradhar,et al.  How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis , 2012, Gastric Cancer.

[6]  M. Dimopoulos,et al.  Molecularly targeted therapies in unresectable-metastatic gastric cancer: a systematic review. , 2011, Cancer treatment reviews.

[7]  C. Liao,et al.  S-1-based therapy versus 5-FU-based therapy in advanced gastric cancer: a meta-analysis , 2011, Medical oncology.

[8]  Gordon H Guyatt,et al.  GRADE guidelines: 9. Rating up the quality of evidence. , 2011, Journal of clinical epidemiology.

[9]  R. Gill,et al.  Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity , 2011, Journal of surgical oncology.

[10]  M. Shah,et al.  Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Susan Mallett,et al.  QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies , 2011, Annals of Internal Medicine.

[12]  A. Hinke,et al.  Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). , 2011, European journal of cancer.

[13]  A. Rosman,et al.  A meta‐analysis of prospective randomized trials comparing minimally invasive and open distal gastrectomy for cancer , 2011, Journal of surgical oncology.

[14]  John Fox,et al.  Cancer Multidisciplinary Team Meetings: Evidence, Challenges, and the Role of Clinical Decision Support Technology , 2011, International journal of breast cancer.

[15]  J. Lagergren,et al.  No further increase in the incidence of esophageal adenocarcinoma in Sweden , 2011, International journal of cancer.

[16]  S. Cui,et al.  Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[18]  Yan Li,et al.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial , 2011, Annals of Surgical Oncology.

[19]  Young-Mi Park,et al.  The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis , 2011, Surgical Endoscopy.

[20]  M. Cuesta,et al.  Laparoscopy versus open surgery for advanced and resectable gastric cancer: a meta-analysis. , 2011, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[21]  G. Fiorentini,et al.  Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis , 2011, Gastric Cancer.

[22]  H. Imamura,et al.  Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002) , 2011, Gastric Cancer.

[23]  A. Nashimoto,et al.  Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2 , 2011, Gastric Cancer.

[24]  K. Behrns.  Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial , 2011 .

[25]  横井 千寿.  Endoscopic submucosal dissection allows curative resection of locally recurrent early gastric cancer after prior endoscopic mucosal resection , 2011 .

[26]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[27]  Hyo-jin Kim,et al.  Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection , 2010, Asia-Pacific journal of clinical oncology.

[28]  Yihong Sun,et al.  Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. , 2010, World journal of gastroenterology.

[29]  Yoon-Koo Kang,et al.  Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial , 2010, The Lancet.

[30]  Yasuo Ohashi,et al.  Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer , 2009 .

[31]  J. Coebergh,et al.  Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. , 2010, European journal of cancer.

[32]  M. Drews,et al.  Adjuvant Chemotherapy with Etoposide, Adriamycin and Cisplatin Compared with Surgery Alone in the Treatment of Gastric Cancer: A Phase III Randomized, Multicenter, Clinical Trial , 2010, Oncology.

[33]  F. Orsi,et al.  Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer. , 2010, World journal of gastroenterology.

[34]  G. Fountzilas,et al.  A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer , 2010, Cancer Chemotherapy and Pharmacology.

[35]  P. A. van den Brandt,et al.  Trends in incidence of oesophageal and stomach cancer subtypes in Europe , 2009, European journal of gastroenterology & hepatology.

[36]  Ke-min Chen,et al.  Determining gastric cancer resectability by dynamic MDCT , 2010, European Radiology.

[37]  J. Windsor,et al.  A systematic review of methods to palliate malignant gastric outlet obstruction , 2010, Surgical Endoscopy.

[38]  G. Hanna,et al.  Laparoscopic assisted distal gastrectomy for early gastric cancer: is it an alternative to the open approach? , 2009, Surgical oncology.

[39]  F. Zaccagna,et al.  Diagnostic performance of 64-MDCT and 1.5-T MRI with highresolution sequences in the T staging of gastric cancer: a comparative analysis with histopathology , 2009, La radiologia medica.

[40]  G. La Torre,et al.  Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  H. Baba,et al.  Extensive Intraoperative Peritoneal Lavage as a Standard Prophylactic Strategy for Peritoneal Recurrence in Patients with Gastric Carcinoma , 2009, Annals of surgery.

[42]  Xin-Zu Chen,et al.  Short-term Evaluation of Laparoscopy-assisted Distal Gastrectomy for Predictive Early Gastric Cancer: A Meta-analysis of Randomized Controlled Trials , 2009, Surgical laparoscopy, endoscopy & percutaneous techniques.

[43]  Y. Bai,et al.  Arsenic trioxide enhances the therapeutic efficacy of adjuvant post-operative chemotherapy of gastric carcinoma while protecting bone marrow , 2009 .

[44]  H. Song,et al.  Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.

[45]  J. Xiang,et al.  Meta‐analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer , 2009, The British journal of surgery.

[46]  E. U. Cidon,et al.  Gastric Adenocarcinoma: Is Computed Tomography (CT) Useful in Preoperative Staging? , 2009, Clinical medicine. Oncology.

[47]  W. Kim,et al.  Diagnostic accuracy of T and N stages with endoscopy, stomach protocol CT, and endoscopic ultrasonography in early gastric cancer , 2009, Journal of surgical oncology.

[48]  Sang Min Lee,et al.  Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer , 2009, Abdominal Imaging.

[49]  J. Choi,et al.  Detecting recurrence of gastric cancer: the value of FDG PET/CT , 2009, Abdominal Imaging.

[50]  Y. Wang,et al.  An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[51]  G. Guyatt,et al.  Going from evidence to recommendations , 2008, BMJ : British Medical Journal.

[52]  R. Labianca,et al.  Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. , 2008, Journal of the National Cancer Institute.

[53]  J. Roh,et al.  Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic-polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[54]  G. Cabibbo,et al.  The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. , 2007, Cancer treatment reviews.

[55]  J. Ji,et al.  Neoadjuvant chemotherapy versus none for resectable gastric cancer. , 2007, Cochrane Database of Systematic Reviews.

[56]  D. Morris,et al.  A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer , 2007, Annals of Surgical Oncology.

[57]  S. Wood-Dauphinée,et al.  Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  J. Pignon,et al.  Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial , 2007 .

[59]  E. Kuipers,et al.  Effects of abdominal hot compresses on indocyanine green elimination – a randomized cross over study in healthy subjects , 2007, BMC gastroenterology.

[60]  Lucia M. A. Crane,et al.  Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival. , 2007, European journal of cancer.

[61]  T. Kwee,et al.  Imaging in local staging of gastric cancer: a systematic review. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  S. Al-Batran,et al.  Chemotherapy for advanced gastric cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  G. Liu,et al.  Gastric cancer: preoperative local staging with 3D multi-detector row CT--correlation with surgical and histopathologic results. , 2007, Radiology.

[64]  J. Fléjou,et al.  Barrett's oesophagus—a pathologist's view , 2007, Histopathology.

[65]  T. Gotoda,et al.  Cancer of the gastric stump following distal gastrectomy for cancer , 2007, The British journal of surgery.

[66]  A. Zinsmeister,et al.  The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub‐site , 2006, Alimentary pharmacology & therapeutics.

[67]  Wang Hy,et al.  Neoadjuvant chemotherapy versus none for resectable gastric cancer (Review) , 2007 .

[68]  H. Ohtani,et al.  Endoscopic stenting versus surgical gastroenterostomy for palliation of malignant gastroduodenal obstruction: a meta-analysis , 2007, Journal of Gastroenterology.

[69]  Y. Kodera,et al.  Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer , 2007, Cancer Immunology, Immunotherapy.

[70]  Hiroshi Ohtani,et al.  Meta-analysis of short-term outcomes after laparoscopy-assisted distal gastrectomy. , 2006, World journal of gastroenterology.

[71]  Shinji Tanaka,et al.  Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. , 2006, Gastrointestinal endoscopy.

[72]  S. Paterson-Brown,et al.  The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[73]  B. Jobe,et al.  Disease-specific multidisciplinary care: a natural progression in the management of esophageal cancer. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[74]  M. Feith,et al.  Adenocarcinoma of the Esophago-Gastric Junction , 2006, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[75]  K. Chayama,et al.  Endoscopic submucosal dissection for residual/local recurrence of early gastric cancer after endoscopic mucosal resection , 2006, Endoscopy.

[76]  R. Odze,et al.  Diagnosis and grading of dysplasia in Barrett’s oesophagus , 2006, Journal of Clinical Pathology.

[77]  W. Kimura,et al.  Surgical management for metastatic liver tumors. , 2006, Hepato-gastroenterology.

[78]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[79]  T. Crosby,et al.  Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[80]  C. Hovendal,et al.  Combined preoperative endoscopic and laparoscopic ultrasonography for prediction of R0 resection in upper gastrointestinal tract cancer , 2006, The British journal of surgery.

[81]  Y. Kodera,et al.  Efficacy of Adjuvant Chemotherapy Using Oral Fluorinated Pyrimidines for Curatively Resected Gastric Cancer: A Meta-Analysis of Centrally Randomized Controlled Clinical Trials in Japan , 2006, Journal of chemotherapy.

[82]  J. Mari,et al.  Chemotherapy versus support cancer treatment in advanced gastric cancer: a meta-analysis. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[83]  A. Tres,et al.  Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[84]  H. Katai,et al.  Follow-up of gastric cancer: a review , 2006, Gastric Cancer.

[85]  T. Marugame,et al.  Cancer Statistics Digest Comparison of Bladder Cancer Mortality in Five Countries : France , Italy , Japan , UK and USA from the WHO Mortality Database ( 1960 – 2000 ) , 2005 .

[86]  M. Ychou,et al.  Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[87]  C. Buskens,et al.  Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction , 2005, Virchows Archiv.

[88]  E. Montgomery.  Is there a way for pathologists to decrease interobserver variability in the diagnosis of dysplasia? , 2005, Archives of pathology & laboratory medicine.

[89]  Dimitrios H Roukos,et al.  Perspectives in the treatment of gastric cancer , 2005, Nature Clinical Practice Oncology.

[90]  Cristiano G S Huscher,et al.  Laparoscopic Versus Open Subtotal Gastrectomy for Distal Gastric Cancer: Five-Year Results of a Randomized Prospective Trial , 2005, Annals of surgery.

[91]  S. Peng,et al.  Surgical management of gastric stump cancer: a report of 37 cases. , 2005, Journal of Zhejiang University. Science. B.

[92]  H. Shimada,et al.  Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer , 2005, Surgical Endoscopy And Other Interventional Techniques.

[93]  H. Han,et al.  A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results , 2005, Surgical Endoscopy And Other Interventional Techniques.

[94]  M. Zembala,et al.  Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer , 2004, Gastric Cancer.

[95]  F. Romano,et al.  Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients. , 2004, Hepato-gastroenterology.

[96]  Dazhi Xu,et al.  Meta-analysis of intraperitoneal chemotherapy for gastric cancer. , 2004, World journal of gastroenterology.

[97]  Janusz Jankowski,et al.  A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. , 2004, Gastroenterology.

[98]  Toshihide Kumamoto,et al.  Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study , 2004, Journal of Gastroenterology.

[99]  N. Basso,et al.  Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. , 2004, American journal of surgery.

[100]  M. Nita,et al.  Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. , 2004, The Cochrane database of systematic reviews.

[101]  A. Mushlin,et al.  Influence of Surgical Subspecialty Training on In-Hospital Mortality for Gastrectomy and Colectomy Patients , 2003, Annals of surgery.

[102]  A. Nashimoto,et al.  Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  Ethan A Halm,et al.  Is Volume Related to Outcome in Health Care? A Systematic Review and Methodologic Critique of the Literature , 2002, Annals of Internal Medicine.

[104]  V. Moreno,et al.  Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995 , 2002, International journal of cancer.

[105]  T. Lehnert,et al.  Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[106]  J. Coebergh,et al.  Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s , 2002, European journal of gastroenterology & hepatology.

[107]  Scott A. Hundahl,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2001, The New England journal of medicine.

[108]  M. Stolte,et al.  Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists , 2001, Journal of Gastroenterology.

[109]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[110]  S. O'mahony,et al.  Endoscopic mucosal resection for early gastric cancer , 2001, Gut.

[111]  S. Yoshida,et al.  Endoscopic mucosal resection for treatment of early gastric cancer , 2001, Gut.

[112]  Y. Nakanishi,et al.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers , 2000, Gastric Cancer.

[113]  M. Stolte,et al.  Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: Proposal for a new classification system of gastrointestinal epithelial neoplasia , 2000, Journal of gastroenterology and hepatology.

[114]  M F Dixon,et al.  The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.

[115]  Y. Tachimori,et al.  Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma , 2000, Cancer.

[116]  S. Dawsey,et al.  Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists , 2000, Cancer.

[117]  M. Rugge,et al.  Gastric dysplasia: the Padova international classification. , 2000, The American journal of surgical pathology.

[118]  M. Stolte,et al.  International comparability of the pathological diagnosis for early cancer of the digestive tract: Munich meeting. , 2000, Journal of gastroenterology.

[119]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[120]  J. Peters,et al.  Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. , 1999, The Journal of thoracic and cardiovascular surgery.

[121]  S. Chung,et al.  Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. , 1999, Gastrointestinal endoscopy.

[122]  H. Stein,et al.  Classification of adenocarcinoma of the oesophagogastric junction , 1998, The British journal of surgery.

[123]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[124]  D. Antonioli,et al.  Morphology of Barrett's esophagus and Barrett's-associated dysplasia and adenocarcinoma. , 1997, Gastroenterology clinics of North America.

[125]  R. Goyal,et al.  The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. , 1996, Gastroenterology.

[126]  R. Haggitt,et al.  Barrett's esophagus, dysplasia, and adenocarcinoma. , 1994, Human pathology.

[127]  M. Koike,et al.  Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. , 1992, Gut.

[128]  K. Takubo,et al.  Double muscularis mucosae in Barrett's esophagus. , 1991, Human pathology.

[129]  L. Sobin,et al.  Histological Typing of Oesophageal and Gastric Tumours , 1990, World Health Organization. International Histological Classification of Tumours.

[130]  C. Rubio,et al.  Histological Classification of Intraepithelial Neoplasias and Microinvasive Squamous Carcinoma of the Esophagus , 1989, The American journal of surgical pathology.

[131]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[132]  B. Reid,et al.  Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. , 1987, Gastroenterology.

[133]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[134]  C. McArdle,et al.  Chemotherapy in advanced gastric cancer. , 1985, Cancer treatment reports.

[135]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[136]  D. Skinner,et al.  Barrett's Esophagus: Comparison of Benign and Malignant Cases , 1983, Annals of surgery.

[137]  F. Ellis,et al.  Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. , 1978, American journal of clinical pathology.

[138]  R. Goyal,et al.  The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.

[139]  M. Savary,et al.  Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. , 1975, The Journal of thoracic and cardiovascular surgery.